Mark Esposito PhD: Founder, VP, and Board Member at Kayothera. - Founding scientist behind Kayothera technology, served as CEO through Series A round. Current head of R&D. - Consultant to several innovative therapeutics platform companies. - Published first author articles in Nature Cancer, Nature Cell Biology, Pharmacology and Therapeutics, etc. - Principal Investigator of two NIH SBIRs and one State of Washington $2M grant awarded to Kayothera, - Experience in medicinal chemistry, cancer genetics, immunology, nonviral gene delivery.